4.7 C
Glasgow
Tuesday, March 3, 2026
spot_img

More News

New lab to speed up diagnostic innovation for biotech and pharma partners

Jim Cornall -
ARUP Laboratories, the largest nonprofit reference laboratory in the US, has launched an Innovation Central Laboratory to facilitate collaboration...

Gallbladder cancer could soon be detected in blood

Jim Cornall -
Researchers at Tezpur University in Assam, India, working with scientists at the University of Illinois Urbana-Champaign, have identified distinct...

Base to Base biotech podcast 48: GPCRs and beating neurodegenerative diseases

Jim Cornall -
The conversations on this week’s podcast are with CEO of Merz Therapeutics, Stefan König, about a variety of neurodegenerative...

Pfizer metastatic colorectal cancer treatment gets FDA approval

Jim Cornall -
Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI (encorafenib)...

Every Cure to receive up to $76m to advance AI-identified drug repurposing opportunities

Jim Cornall -
Every Cure, a nonprofit with a mission to save and improve lives by repurposing existing medicines, has been selected...

Key protein in Alzheimer’s disease protection

Jim Cornall -
Alzheimer’s disease affects approximately 50m people worldwide and is a devastating disease with limited treatment options currently available. "Alzheimer's is...

Machine-learning biomarker identifies those at high risk for liver cancer

Jim Cornall -
Researchers led by Xian-Yang Qin at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have developed a...

New AI approach enables diagnosis and monitoring of brain tumours

Jim Cornall -
An international research team, with significant involvement from the Medical University of Vienna, has developed a new AI-based analysis...

Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins

Jim Cornall -
Nuclera and leadXpro are set to collaborate by bringing together eProtein Discovery's rapid multiplex membrane protein screening with leadXpro's...

Korsana Biosciences emerges from stealth with $175m to tackle neurodegenerative diseases

Jim Cornall -
Korsana Biosciences, Inc., a biotechnology company discovering and developing novel therapies to reduce the burden of neurodegenerative diseases, has...

New centre for cell research

Jim Cornall -
A new centre for cell research is being set up at the University of Konstanz in Germany. The Single Cell...

PLL Therapeutics reports results from ALS trial

Jim Cornall -
PLL Therapeutics, a biopharmaceutical company developing a groundbreaking polypeptide delivery platform to treat the root cause of autoimmune and...

Aggressive oral cancer can be identified at an early stage by changes in lymphatic vessels

Jim Cornall -
Oral cancers are the most common malignant tumours in the head and neck region, causing more than 188,000 deaths...

Stopping malignant stem cells from becoming cancer cells

Jim Cornall -
In a new study in Nature Communications, a research team at the University of Oslo in Norway have examined...

Bacteria with built-in compass could be used as microbots for drug delivery

Jim Cornall -
Some bacterial species can use the Earth’s magnetic field to orient themselves. To better understand this, a team led by...

Base to Base biotech podcast 47: Accurate prostate cancer diagnosis and ocular gene therapy

Jim Cornall -
The conversations on this week’s podcast focus on a rapid and accurate prostate cancer diagnostic test, with Valley Diagnostics’...

Modifying CAR T-cells to kill solid tumours

Jim Cornall -
A team led by LMU physician Sebastian Kobold has found a way to allow the body’s immune system to...

New company created to tackle paediatric cerebral palsy

Jim Cornall -
Kidswell Bio Corporation and Treehill Partners are creating a new US-based regenerative medicine company, Kidswell USA. It is being formed...

Strategic partnership to advance space-based life sciences research infrastructure

Jim Cornall -
Azenta, Inc. has announced a strategic partnership with Frontier Space to conduct scientific experiments in space. The collaboration aims to...

HanchorBio receives FDA Orphan Drug Designation for gastric cancer drug

Jim Cornall -
HanchorBio, Inc. has announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) to its...

Collaboration to develop novel therapies for neutrophil-derived inflammatory diseases

Jim Cornall -
Evogene Ltd., Systasy Bioscience GmbH, and LMU University Hospital Munich, are set to collaborate to accelerate the development of...

Deeptech Digest is your guide to what's new in at the cutting edge of science technology. A bit of artificial intelligence, some biotech, and all the news and latests developments in the field. If it's deeptech, it's in Deeptech Digest!

Contact us: jim@deeptechdigest.com

© 2023 Ayr Coastal Media